UPC (Universe Pharmaceuticals) Short Ratio


UPC Universe Pharmaceuticals Inc UPC
63 GF Score
Price $6.32
GF Value $5.20
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Universe Pharmaceuticals Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

UPC
63GF Score
Universe Pharmaceuticals Inc UPC
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Universe Pharmaceuticals (UPC) Overvalued in 2026?

Based on GuruFocus' analysis, Universe Pharmaceuticals stock appears to be overvalued. The current stock price of $6.32 is trading 21.5% above its estimated GF Value™ of $5.20. GuruFocus considers Universe Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for UPC:

  • Short Ratio:
  • GF Value™: $5.20 vs. price of $6.32 (21.5% above fair value)
  • GF Score™: 63/100 with 7 warning signs

No single metric tells the full story. See the UPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universe Pharmaceuticals Business Description

Address 265 Jingjiu Avenue, Jinggangshan Economic & Technological Development Zone, Jiangxi, Ji’an, CHN, 343100
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
63GF Score

Get the complete analysis for UPC

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.32
Price
$5.20
GF Value